New developments on the TNFα-mediated signalling pathways

Bioscience Reports

Volumn 31, Issue 1, 2011, Pages 63-76

  Sethu, Swaminathan ^a   Melendez, Alirio J ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Apoptosis; Cell survival; Inflammation; Lipid; Nuclear factor B (NF B); Signal transduction; TNF (tumour necrosis factor )

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CASPASE; CYTOSOLIC PHOSPHOLIPASE A2; FAS ASSOCIATED DEATH DOMAIN PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE C; PHOSPHOLIPASE D; SPHINGOSINE KINASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN;

ANKYLOSING SPONDYLITIS; APOPTOSIS; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CELL PROLIFERATION; CELL SURVIVAL; CONFORMATIONAL TRANSITION; CROHN DISEASE; DEMYELINATING DISEASE; DRUG EFFECT; DRUG EFFICACY; ENDOMETRIOSIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GRANULOMATOSIS; HUMAN; IMMUNOREACTIVITY; INFECTION SENSITIVITY; INFLAMMATORY DISEASE; INTRACELLULAR SIGNALING; LIGAND BINDING; LISTERIOSIS; LUPUS VULGARIS; MYCOBACTERIOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PARASITOSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN TARGETING; RECEPTOR BINDING; REVIEW; RHEUMATOID ARTHRITIS; TRANSCRIPTION INITIATION; VIRUS INFECTION;

ANIMALS; CELL COMMUNICATION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIGANDS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952223781     PISSN: 01448463     EISSN: None     Source Type: Journal    
DOI: 10.1042/BSR20100040     Document Type: Review

References (208)

1. Tracey, K. J. and Cerami, A. (1994) Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45, 491-503
2. Tracey, K. J. and Cerami, A. (1993) Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9, 317-343
3. Baud, V. and Karin, M. (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11, 372-377 (Pubitemid 32900529)
4. Chen, G. and Goeddel, D. V. (2002) TNF-R1 signaling: a beautiful pathway. Science 296, 1634-1635
5. MacEwan, D. J. (2002) TNF ligands and receptors - a matter of life and death. Br. J. Pharmacol. 135, 855-875
6. Hehlgans, T. and Mannel, D. N. (2002) The TNF-TNF receptor system. Biol. Chem. 383, 1581-1585
7. Aggarwal, B. B. (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3, 745-756
8. Lin, J., Ziring, D., Desai, S., Kim, S., Wong, M., Korin, Y., Braun, J., Reed, E., Gjertson, D. and Singh, R. R. (2008) TNFα blockade in human diseases: an overview of efficacy and safety. Clin. Immunol. 126, 13-30
9. Wong, M., Ziring, D., Korin, Y., Desai, S., Kim, S., Lin, J., Gjertson, D., Braun, J., Reed, E. and Singh, R. R. (2008) TNFα blockade in human diseases: mechanisms and future directions. Clin. Immunol. 126, 121-136
10. Bruns, P. (1868) Die Heilwirkung des Erysipels auf Geschwulste Beitr. Klin. Chir. 3, 443-446
11. Coley, W. B. (1891) Contribution to the knowledge of Sarcoma. Ann. Surg. 14, 199-220
12. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N. and Williamson, B. (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. U. S. A. 72, 3666-3670
13. Old, L. J. (1985) Tumor necrosis factor (TNF). Science 230, 630-632
14. Aggarwal, B. B., Kohr, W. J., Hass, P. E., Moffat, B., Spencer, S. A., Henzel, W. J., Bringman, T. S., Nedwin, G. E., Goeddel, D. V. and Harkins, R. N. (1985) Human tumor necrosis factor. Production, purification, and characterization. J. Biol. Chem. 260, 2345-2354
15. Aggarwal, B. B., Moffat, B. and Harkins, R. N. (1984) Human lymphotoxin production by a lymphoblastoid cell line, purification, and initial characterization. J. Biol. Chem. 259, 686-691
16. Clark, I. A. (2007) How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev. 18, 335-343
17. Gearing, A. J., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L. et al. (1994) Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370, 555-557 (Pubitemid 24264920)
18. Black, R. A. (2002) Tumor necrosis factor-α converting enzyme. Int. J. Biochem. Cell Biol. 34, 1-5
19. Idriss, H. T. and Naismith, J. H. (2000) TNF α and the TNF receptor superfamily: structure-function relationship(s). Microsc. Res. Tech. 50, 184-195
20. Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S. et al. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385, 729-733 (Pubitemid 27098094)
21. Moss, M. L., Jin, S. L., Milla, M. E., Bickett, D. M., Burkhart, W., Carter, H. L., Chen, W. J., Clay, W. C., Didsbury, J. R., Hassler, D. et al. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385, 733-736 (Pubitemid 27098095)
22. Sprang, S. R. and Eck, M. J. (1992) The 3-D structure of TNF. In Tumor Necrosis Factors: the Molecules and Their Emerging Role in Medicine (Beutler, B, ed.), pp. 11-32, Raven Press, New York, USA
23. Darnay, B. G. and Aggarwal, B. B. (1999) Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors. Ann. Rheum. Dis. 58 (Suppl. 1), 12-113
24. Ware, C. F. (2008) The TNF Superfamily-2008. Cytokine Growth Factor Rev. 19, 183-186
25. MacEwan, D. J. (2002) TNF receptor subtype signalling: differences and cellular consequences. Cell. Signalling 14, 477-492
26. Smith, C. A., Davis, T., Anderson, D., Solam, L., Beckmann, M. P., Jerzy, R., Dower, S. K., Cosman, D. and Goodwin, R. G. (1990) A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248, 1019-1023
27. Vandenabeele, P., Declercq, W., Beyaert, R. and Fiers, W. (1995) Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 5, 392-399
28. Chan, F. K., Chun, H. J., Zheng, L., Siegel, R. M., Bui, K. L. and Lenardo, M. J. (2000) A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288, 2351-2354 (Pubitemid 30448156)
29. Grell, M. (1995) Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF. J. Inflamm. 47, 8-17
30. Grell, M., Douni, E., Wajant, H., Lohden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K. and Scheurich, P. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80kDa tumor necrosis factor receptor. Cell 83, 793-802
31. Grell, M., Wajant, H., Zimmermann, G. and Scheurich, P. (1998) The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc. Natl. Acad. Sci. U. S. A. 95, 570-575
32. Wajant, H., Pfizenmaier, K. and Scheurich, P. (2003) Tumor necrosis factor signaling. Cell Death Differ. 10, 45-65
33. Seitz, C., Muller, P., Krieg, R. C., Mannel, D. N. and Hehlgans, T. (2001) A novel p75TNF receptor isoform mediating NF-κ-B activation. J. Biol. Chem. 276, 19390-19395
34. Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V. and Boldin, M. P. (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17, 331-367
35. Tartaglia, L. A., Ayres, T. M., Wong, G. H. and Goeddel, D. V. (1993) A novel domain within the 55 kd TNF receptor signals cell death. Cell 74, 845-853
36. Jiang, Y., Woronicz, J. D., Liu, W. and Goeddel, D. V. (1999) Prevention of constitutive TNF receptor 1signaling by silencer of death domains. Science 283, 543-546
37. Higuchi, M. and Aggarwal, B. B. (1994) Differential roles of two types of the TNF receptor in TNF-induced cytotoxicity, DNA fragmentation, and differentiation. J. Immunol. 152, 4017-4025 (Pubitemid 24111073)
38. Schutze, S., Machleidt, T., Adam, D., Schwandner, R., Wiegmann, K., Kruse, M. L., Heinrich, M., Wickel, M. and Kranke, M. (1999) Inhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling. J. Biol. Chem. 274, 10203-10212
39. Hsu, H., Shu, H. B., Pan, M. G. and Goeddel, D. V. (1996) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308
40. Liu, Z. G., Hsu, H., Goeddel, D. V. and Karin, M. (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565-576 (Pubitemid 26374329)
41. Wyllie, A. H. (1997) Apoptosis and carcinogenesis. Eur. J. Cell Biol. 73, 189-197
42. Denecker, G., Vercammen, D., Declercq, W. and Vandenabeele, P. (2001) Apoptotic and necrotic cell death induced by death domain receptors. Cell. Mol. Life Sci. 58, 356-370
43. Denecker, G., Vercammen, D., Steemans, M., Vanden Berghe, T., Brouckaert, G., Van Loo, G., Zhivotovsky, B., Fiers, W., Grooten, J., Declercq, W. and Vandenabeele, P. (2001) Death receptor- induced apoptotic and necrotic cell death: differential role of caspases and mitochondria. Cell Death Differ. 8, 829-840 (Pubitemid 32725534)
44. Mak, T. W. and Yeh, W. C. (2002) Signaling for survival and apoptosis in the immune system. Arthritis Res. 4 (Suppl. 3), S243-S252
45. Hsu, H., Xiong, J. and Goeddel, D. V. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81, 495-504
46. Ashkenazi, A. and Dixit, V. M. (1998) Death receptors: signaling and modulation. Science 281, 1305-1308
47. Luo, X., Budihardjo, I., Zou, H., Slaughter, C. and Wang, X. (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481-490 (Pubitemid 28391864)
48. Wang, X. (2001) The expanding role of mitochondria in apoptosis. Genes Dev. 15, 2922-2933
49. Wieder, T., Essmann, F., Prokop, A., Schmelz, K., Schulze-Osthoff, K., Beyaert, R., Dorken, B. and Daniel, P. T. (2001) Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3. Blood 97, 1378-1387
50. Davis, R. J. (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252
51. Jupp, O. J., McFarlane, S. M., Anderson, H. M., Littlejohn, A. F., Mohamed, A. A., MacKay, R. H., Vandenabeele, P. and MacEwan, D. J. (2001) Type II tumour necrosis factor-α receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways. Biochem. J. 359, 525-535 (Pubitemid 33063376)
52. Baud, V., Liu, Z. G., Bennett, B., Suzuki, N., Xia, Y. and Karin, M. (1999) Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev. 13, 1297-1308 (Pubitemid 29250197)
53. Natoli, G., Costanzo, A., Ianni, A., Templeton, D. J., Woodgett, J. R., Balsano, C. and Levrero, M. (1997) Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275, 200-203
54. Ichijo, H., Nishida, E., Irie, K., ten Dijke, P., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K. and Gotoh, Y. (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90-94
55. Nishitoh, H., Saitoh, M., Mochida, Y., Takeda, K., Nakano, H., Rothe, M., Miyazono, K. and Ichijo, H. (1998) ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell 2, 389-395 (Pubitemid 128379279)
56. Yuasa, T., Ohno, S., Kehrl, J. H. and Kyriakis, J. M. (1998) Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J. Biol. Chem. 273, 22681-22692
57. Weston, C. R. and Davis, R. J. (2002) The JNK signal transduction pathway. Curr. Opin. Genet. Dev. 12, 14-21
58. Lamb, J. A., Ventura, J. J., Hess, P., Flavell, R. A. and Davis, R. J. (2003) JunD mediates survival signaling by the JNK signal transduction pathway. Mol. Cell 11, 1479-1489 (Pubitemid 36776535)
59. Ventura, J. J., Cogswell, P., Flavell, R. A., Baldwin, Jr, A. S. and Davis, R. J. (2004) JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Genes Dev. 18, 2905-2915 (Pubitemid 39602309)
60. Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K. and Ichijo, H. (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17, 2596-2606
61. Gotoh, Y. and Cooper, J. A. (1998) Reactive oxygen species-and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-α signal transduction. J. Biol. Chem. 273, 17477-17482
62. Kamata, H., Honda, S., Maeda, S., Chang, L., Hirata, H. and Karin, M. (2005) Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649-661 (Pubitemid 40343077)
63. Shen, H. M. and Pervaiz, S. (2006) TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J. 20, 1589-1598
64. Karin, M., Liu, Z. and Zandi, E. (1997) AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240-246
65. Kyriakis, J. M. and Avruch, J. (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807-869
66. Lin, Y., Devin, A., Rodriguez, Y. and Liu, Z. G. (1999) Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 13, 2514-2526
67. Pilane, C. M. and LaBelle, E. F. (2002) Arachidonic acid release by CPLA2 may be causally related to NO-induced apoptosis in vascular smooth muscle cells. J. Cell. Physiol. 191, 191-197
68. Wolf, L. A. and Laster, S. M. (1999) Characterization of arachidonic acid-induced apoptosis. Cell Biochem. Biophys. 30, 353-368
69. Pirianov, G., Danielsson, C., Carlberg, C., James, S. Y. and Colston, K. W. (1999) Potentiation by vitamin D analogs of TNFα and ceramide-induced apoptosis in MCF-7 cells is associated with activation of cytosolic phospholipase A2. Cell Death Differ. 6, 890-901
70. Lee, C., Park, D. W., Lee, J., Lee, T. I., Kim, Y J., Lee, Y. S. and Baek, S. H. (2006) Secretory phospholipase A2 induces apoptosis through TNF-α and cytochrome c-mediated caspase cascade in murine macrophage RAW 264.7 cells. Eur. J. Pharmacol. 536, 47-53
71. Thommesen, L., Sjursen, W., Gasvik, K., Hanssen, W., Brekke, O. L., Skattebol, L., Holmeide, A. K., Espevik, T., Johansen, B. and Laegreid, A. (1998) Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-κB and expression of ICAM-1. J. Immunol. 161, 3421-3430
72. Anthonsen, M. W., Solhaug, A. and Johansen, B. (2001) Functional coupling between secretory and cytosolic phospholipase A2 modulates tumor necrosis factor-α- and interleukin-1β-induced NF-κB activation. J. Biol. Chem. 276, 30527-30536
73. De Valck, D., Vercammen, D., Fiers, W. and Beyaert, R. (1998) Differential activation of phospholipases during necrosis or apoptosis: a comparative study using tumor necrosis factor and anti-Fas antibodies. J. Cell. Biochem. 71, 392-399
74. Wu, Y. L., Jiang, X. R., Newland, A. C. and Kelsey, S. M. (1998) Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells. J. Immunol. 160, 5929-5935
75. Wu, Y. L., Jiang, X. R., Lillington, D. M., Allen, P. D., Newland, A. C. and Kelsey, S. M. (1998) 1,25-Dihydroxyvitamin D3 protects human leukemic cells from tumor necrosis factor-induced apoptosis via inactivation of cytosolic phospholipase A2. Cancer Res. 58, 633-640
76. Jayadev, S., Hayter, H. L., Andrieu, N., Gamard, C. J., Liu, B., Balu, R., Hayakawa, M., Ito, F. and Hannun, Y. A. (1997) Phospholipase A2 is necessary for tumor necrosis factor α-induced ceramide generation in L929 cells. J. Biol. Chem. 272, 17196-17203
77. Clark, J. D., Lin, L. L., Kriz, R. W., Ramesha, C. S., Sultzman, L. A., Lin, A. Y., Milona, N. and Knopf, J. L. (1991) A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell 65, 1043-1051
78. MacEwan, D. J. (1996) Elevated cPLA2 levels as a mechanism by which the p70 TNF and p75 NGF receptors enhance apoptosis. FEBS Lett. 379, 77-81
79. Hoeck, W. G., Ramesha, C. S., Chang, D. J., Fan, N. and Heller, R. A. (1993) Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc. Natl. Acad. Sci. U. S. A. 90, 4475-4479
80. Chang, D. J., Ringold, G. M. and Heller, R. A. (1992) Cell killing and induction of manganous superoxide dismutase by tumor necrosis factor-α is mediated by lipoxygenase metabolites of arachidonic acid. Biochem. Biophys. Res. Commun. 188, 538-546
81. Chung, J. Y., Park, Y. C., Ye, H. and Wu, H. (2002) All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J. Cell Sci. 115, 679-688
82. Xia, Z. P. and Chen, Z. J. (2005) TRAF2: a double-edged sword? Sci. STKE 2005, pe7
83. Park, Y. C., Ye, H., Hsia, C., Segal, D., Rich, R. L., Liou, H. C., Myszka, D. G. and Wu, H. (2000) A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction. Cell 101, 777-787
84. Devin, A., Cook, A., Lin, Y., Rodriguez, Y., Kelliher, M. and Liu, Z. (2000) The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12, 419-429
85. Kelliher, M. A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B. Z. and Leder, P. (1998) The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8, 297-303
86. Tada, K., Okazaki, T., Sakon, S., Kobarai, T., Kurosawa, K., Yamaoka, S., Hashimoto, H., Mak, T. W., Yagita, H., Okumura, K. et al. (2001) Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-κB activation and protection from cell death. J. Biol. Chem. 276, 36530-36534
87. Ghosh, S., May, M. J. and Kopp, E. B. (1998) NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260
88. Baeuerle, P. A. and Henkel, T. (1994) Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141-179
89. Zhou, Z., Connell, M. C. and MacEwan, D. J. (2007) TNFR1-induced NF-κB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell. Signalling 19, 1238-1248
90. Hayden, M. S. and Ghosh, S. (2004) Signaling to NF-κB. Genes Dev. 18, 2195-2224
91. Pomerantz, J. L. and Baltimore, D. (2002) Two pathways to NF-κB. Mol. Cell 10, 693-695
92. Hoffmann, A. and Baltimore, D. (2006) Circuitry of nuclear factor κB signaling. Immunol. Rev. 210, 171-186
93. Ghosh, S. and Karin, M. (2002) Missing pieces in the NF-κB puzzle. Cell (Suppl.) 109, S81-S96
94. Devin, A., Lin, Y., Yamaoka, S., Li, Z., Karin, M. and Liu, Z. (2001) The α and κ subunits of IκB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF. Mol. Cell. Biol. 21, 3986-3994
95. Zhang, S. Q., Kovalenko, A., Cantarella, G. and Wallach, D. (2000) Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. Immunity 12, 301-311
96. Malinin, N. L., Boldin, M. P., Kovalenko, A. V. and Wallach, D. (1997) MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385, 540-544
97. Ling, L., Cao, Z. and Goeddel, D. V. (1998) NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176. Proc. Natl. Acad. Sci. U. S. A. 95, 3792-3797
98. Karin, M. and Ben-Neriah, Y (2000) Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18, 621-663
99. Tang, G., Minemoto, Y., Dibling, B., Purcell, N. H., Li, Z., Karin, M. and Lin, A. (2001) Inhibition of JNK activation through NF-κB target genes. Nature 414, 313-317
100. De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D. U., Jin, R., Jones, J., Cong, R. and Franzoso, G. (2001) Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling. Nature 414, 308-313
101. Shu, H. B., Halpin, D. R. and Goeddel, D. V. (1997) Casper is a FADD- and caspase-related inducer of apoptosis. Immunity 6, 751-763
102. Amanullah, A., Azam, N., Balliet, A., Hollander, C., Hoffman, B., Fornace, A. and Liebermann, D. (2003) Cell signalling: cell survival and a Gadd45-factor deficiency. Nature 424, 741
103. Harlin, H., Reffey, S. B., Duckett, C. S., Lindsten, T. and Thompson, C. B. (2001) Characterization of XIAP-deficient mice. Mol. Cell. Biol. 21, 3604-3608
104. Papa, S., Bubici, C., Pham, C. G., Zazzeroni, F. and Franzoso, G. (2005) NF-κB meets ROS: an 'iron-ic' encounter. Cell Death Differ. 12, 1259-1262
105. Zhang, Y. and Chen, F. (2004) Reactive oxygen species (ROS), troublemakers between nuclear factor-κB (NF-κB) and c-Jun NH(2)-terminal kinase (JNK). Cancer Res. 64, 1902-1905
106. Delhalle, S., Deregowski, V., Benoit, V., Merville, M. P. and Bours, V. (2002) NF-κB-dependent MnSOD expression protects adenocarcinoma cells from TNF-α-induced apoptosis. Oncogene 21, 3917-3924
107. Pham, C. G., Bubici, C., Zazzeroni, F., Papa, S., Jones, J., Alvarez, K., Jayawardena, S., De Smaele, E., Cong, R., Beaumont, C., Torti, F. M., Torti, S. V. and Franzoso, G. (2004) Ferritin heavy chain upregulation by NF-κB inhibits TNFα-induced apoptosis by suppressing reactive oxygen species. Cell 119, 529-542
108. Liochev, S. I. and Fridovich, I. (1997) How does superoxide dismutase protect against tumor necrosis factor: a hypothesis informed by effect of superoxide on 'free' iron. Free Radical Biol. Med. 23, 668-671
109. Madrid, L. V., Mayo, M. W., Reuther, J. Y. and Baldwin, Jr, A. S. (2001) Akt stimulates the transactivation potential of the RelA/P65 Subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276, 18934-18940
110. Delhase, M., Li, N. and Karin, M. (2000) Kinase regulation in inflammatory response. Nature 406, 367-368
111. Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M. S., Jin, O. and Woodgett, J. R. (2000) Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature 406, 86-90
112. Shu, H. B., Takeuchi, M. and Goeddel, D. V. (1996) The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor lsignaling complex. Proc. Natl. Acad. Sci. U. S. A. 93, 13973-13978
113. Rothe, M., Pan, M. G., Henzel, W. J., Ayres, T. M. and Goeddel, D. V. (1995) The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83, 1243-1252
114. Roy, N., Deveraux, Q. L., Takahashi, R., Salvesen, G. S. and Reed, J. C. (1997) The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 16, 6914-6925
115. Huang, H., Joazeiro, C. A., Bonfoco, E., Kamada, S., Leverson, J. D. and Hunter, T. (2000) The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J. Biol. Chem. 275, 26661-26664
116. Schutze, S., Berkovic, D., Tomsing, O., Unger, C. and Kronke, M. (1991) Tumor necrosis factor induces rapid production of 1′2′diacylglycerol by a phosphatidylcholine-specific phospholipase C. J. Exp. Med. 174, 975-988
117. Wiegmann, K., Schutze, S., Kampen, E., Himmler, A., Machleidt, T. and Kronke, M. (1992) Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J. Biol. Chem. 267, 17997-18001
118. Pio, I., Lautier, D., Levade, T., Sekouri, H., Jaffrezou, J. P., Laurent, G. and Bettaieb, A. (2000) Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and nuclear factor κB activation in tumour-necrosis-factor-α-treated immature acute-myeloid-leukaemla cells. Biochem. J. 351, 459-467
119. Nishizuka, Y. (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C Science 258, 607-614
120. De Valck, D., Beyaert, R., Van Roy, F. and Fiers, W. (1993) Tumor necrosis factor cytotoxicity is associated with phospholipase D activation. Eur. J. Biochem. 212, 491-497
121. Kang, J. H., Shin, I. and Han, J. S. (1998) Changes of phospholipase D activity in TNF-α and anti-Fas/Apo1 monoclonal antibody induced apoptosis in HL-60 and A20 cells. Exp. Mol. Med. 30, 21-27
122. Oprins, J. C., van der Burg, C., Meijer, H. P., Munnik, T. and Groot, J. A. (2001) PLD pathway involved in carbachol-induced CI- secretion: possible role of TNF-α. Am. J. Physiol. Cell Physiol. 280, C789-C795
123. Bechoua, S. and Daniel, L. W. (2001) Phospholipase D is required in the signaling pathway leading to p38 MAPK activation in neutrophil-like HL-60 cells, stimulated by N-formyl-methionyl-leucyl-phenylalanine. J. Biol. Chem. 276, 31752-31759
124. Oprins, J. C., van der Burg, C., Meijer, H. P., Munnik, T. and Groot, J. A. (2002) Tumour necrosis factor α potentiates ion secretion induced by histamine in a human intestinal epithelial cell line and in mouse colon: involvement of the phospholipase D pathway. Gut 50, 314-321
125. Gomez-Cambronero, J. and Keire, P. (1998) Phospholipase D: a novel major player in signal transduction. Cell Signalling 10, 387-397
126. Jenkins, G. M. and Frohman, M. A. (2005) Phospholipase D: a lipid centric review. Cell. Mol. Life Sci. 62, 2305-2316
127. Huang, P. and Frohman, M. A. (2007) The potential for phospholipase D as a new therapeutic target. Expert Opin. Ther. Targets 11, 707-716
128. McDermott, M., Wakelam, M. J. and Morris, A. J. (2004) Phospholipase D. Biochem. Cell Biol. 82, 225-253
129. Melendez, A. J. and Allen, J. M. (2002) Phospholipase D and immune receptor signalling. Semin. Immunol. 14, 49-55
130. Sethu, S., Mendez-Corao, G. and Melendez, A. J. (2008) Phospholipase D1 plays a key role in TNF-α signaling. J. Immunol. 180, 6027-6034
131. Melendez, A. J. and Sethu, S. (2007) Role of PLD and SPHK in TNFα Signaling and Effector Responses, Department of Physiology, National University of Singapore, Singapore
132. Andresen, B. T., Rizzo, M. A., Shome, K. and Romero, G. (2002) The role of phosphatidic acid in the regulation of the Ras/MEK/Erk signaling cascade. FEBS Lett. 531, 65-68
133. Nozawa, Y. (2002) Roles of phospholipase D in apoptosis and pro-survival. Biochim. Biophys. Acta 1585, 77-86
134. Birbes, H., Zeiller, C., Komati, H., Nemoz, G., Lagarde, M. and Prigent, A. F. (2006) Phospholipase D protects ECV304 cells against TNFα-induced apoptosis. FEBS Lett. 580, 6224-6232
135. Parinandi, N. L., Scribner, W. M., Vepa, S., Shi, S. and Natarajan, V. (1999) Phospholipase D activation in endothelial cells is redox sensitive. Antioxid. Redox Signalling 1, 193-210
136. Schutze, S., Machleidt, T. and Kranke, M. (1994) The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J. Leukocyte Biol. 56, 533-541
137. Lee, J. Y., Hannun, Y. A. and Obeid, L. M. (2000) Functional dichotomy of protein kinase C (PKC) in tumor necrosis factor-α (TNF-α) signal transduction in L929 cells. Translocation and inactivation of PKC by TNF-α. J. Biol. Chem. 275, 29290-29298
138. Laouar, A., Glesne, D. and Huberman, E. (1999) Involvement of protein kinase C-β and ceramide in tumor necrosis factor-α-induced but not Fas-induced apoptosis of human myeloid leukemia cells. J. Biol. Chem. 274, 23526-23534
139. Cohen, G. M. (1997) Caspases: the executioners of apoptosis. Biochem. J. 326, 1-16
140. Muller, G., Ayoub, M., Storz, P., Rennecke, J., Fabbro, D. and Pfizenmaier, K. (1995) PKC zeta is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14, 1961-1969
141. Sanz, L., Sanchez, P., Lallena, M. J., Diaz-Meco, M. T. and Moscat, J. (1999) The interaction of p62 with RIP links the atypical PKCs to NF-κB activation. EMBO J. 18, 3044-3053
142. Bonizzi, G., Piette, J., Schoonbroodt, S., Merville, M. P. and Bours, V. (1999) Role of the protein kinase C lambda/iota isoform in nuclear factor-κB activation by interleukin-1β or tumor necrosis factor-α: cell type specificities. Biochem. Pharmacol. 57, 713-720
143. Dressler, K. A., Mathias, S. and Kolesnick, R. N. (1992) Tumor necrosis factor-α activates the sphingomyelin signal transduction pathway in a cell-free system. Science 255, 1715-1718
144. Chatterjee, S. (1994) Neutral sphingomyelinase action stimulates signal transduction of tumor necrosis factor-α in the synthesis of cholesteryl esters in human fibroblasts. J. Biol. Chem. 269, 879-882
145. Schutze, S., Potthoff, K., Machleidt, T., Berkovic, D., Wiegmann, K. and Kranke, M. (1992) TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced 'acidic' sphingomyelin breakdown. Cell 71, 765-776
146. Wiegmann, K., Schutze, S., Machleidt, T., Witte, D. and Kranke, M. (1994) Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78, 1005-1015
147. Quintern, L. E., Weitz, G., Nehrkorn, H., Tager, J. M., Schram, A. W. and Sandhoff, K. (1987) Acid sphingomyelinase from human urine: purification and characterization. Biochim. Biophys. Acta 922, 323-336
148. Kolesnick, R. N. (1987) 1,2-Diacylglycerols but not phorbol esters stimulate sphingomyelin hydrolysis in GH3 pituitary cells. J. Biol. Chem. 262, 16759-16762
149. Yang, Z., Costanzo, M., Golde, D. W. and Kolesnick, R. N. (1993) Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor κB translocation in intact HL-60 cells. J. Biol. Chem. 268, 20520-20523
150. Mallampalli, R. K., Peterson, E. J., Carter, A. B., Salome, R. G., Mathur, S. N. and Koretzky, G. A. (1999) TNF-α increases ceramide without inducing apoptosis in alveolar type II epithelial cells. Am. J. Physiol. 276, L481-L490
151. Dbaibo, G. S., Obeid, L. M. and Hannun, Y. A. (1993) Tumor necrosis factor-α (TNF-α) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF-α from activation of nuclear factor-κB. J. Biol. Chem. 268, 17762-17766
152. Pyne, S. and Pyne, N. J. (2000) Sphingosine 1-phosphate signalling in mammalian cells. Biochem. J. 349, 385-402
153. Kee, T. H., Vit, P. and Melendez, A. J. (2005) Sphingosine kinase signalling in immune cells. Clin. Exp. Pharmacol. Physiol. 32, 153-161
154. Melendez, A. J. (2008) Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets. Biochim. Biophys. Acta 1784, 66-75
155. Zhi, L., Leung, B. P. and Melendez, A. J. (2006) Sphingosine kinase 1 regulates pro-inflammatory responses triggered by TNFa in primary human monocytes. J. Cell. Physiol. 208, 109-115
156. Barone, F. C., Irving, E. A., Ray, A. M., Lee, J. C., Kassis, S., Kumar, S., Badger, A. M., Legos, J. J., Erhardt, J. A., Ohlstein, E. H. et al. (2001) Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med. Res. Rev. 21, 129-145
157. Nakada, S., Kawano, T., Saito-akita, S., Iwase, S., Horiguchi-Yamada, J., Ohno, T. and Yamada, H. (2001) MEK and p38MAPK inhibitors potentiate TNF-α induced apoptosis in U937 cells. Anticancer Res. 21, 167-171
158. Roux, P. P. and Blenis, J. (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68, 320-344
159. Enslen, H., Raingeaud, J. and Davis, R. J. (1998) Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem. 273, 1741-1748
160. Beyaert, R., Cuenda, A., Vanden Berghe, W., Plaisance, S., Lee, J. C., Haegeman, G., Cohen, P. and Fiers, W. (1996) The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 15, 1914-1923
161. Scheid, M. P. and Duronio, V. (1998) Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 95, 7439-7444
162. Vanhaesebroeck, B. and Alessi, D. R. (2000) The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346, 561-576
163. Ozes, O. N., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M. and Donner, D. B. (1999) NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401, 82-85
164. Burow, M. E., Weldon, C. B., Melnik, L. I., Duong, B. N., Collins-Burow, B. M., Beckman, B. S. and McLachlan, J. A. (2000) PI3-K/AKT regulation of NF-κB signaling events in suppression of TNF-induced apoptosis. Biochem. Biophys. Res. Commun. 271, 342-345
165. Bieler, G., Hasmim, M., Monnier, Y., Imaizumi, N., Ameyar, M., Bamat, J., Ponsonnet, L., Chouaib, S., Grell, M., Goodman, S. L. et al. (2007) Distinctive role of integrin-mediated adhesion in TNF-induced PKB/Akt and NF-κB activation and endothelial cell survival. Oncogene 26, 5722-5732
166. Widmann, C., Gibson, S. and Johnson, G. L. (1998) Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J. Biol. Chem. 273, 7141-7147
167. Schubert, K. M., Scheid, M. P. and Duronio, V. (2000) Ceramide inhibits protein kinase B/Akt by promoting dephosphorylation of serine 473. J. Biol. Chem. 275, 13330-13335
168. Zinda, M. J., Vlahos, C. J. and Lai, M. T. (2001) Ceramide induces the dephosphorylation and inhibition of constitutively activated Akt in PTEN negative U87mg cells. Biochem. Biophys. Res. Commun. 280, 1107-1115
169. Li, J., Yang, S. and Billiar, T. R. (2000) Cyclic nucleotides suppress tumor necrosis factor α-mediated apoptosis by Inhibiting caspase activation and cytochrome c release in primary hepatocytes via a mechanism independent of Akt activation. J. Biol. Chem. 275, 13026-13034
170. Kohno, M. and Pouyssegur, J. (2003) Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs. Prog. Cell Cycle Res. 5, 219-224
171. Chen, Z., Gibson, T. B., Robinson, F., Silvestro, L., Pearson, G., Xu, B., Wright, A., Vanderbilt, C. and Cobb, M. H. (2001) MAP kinases. Chem. Rev. 101, 2449-2476
172. Van Lint, J., Agostinis, P., Vandevoorde, V., Haegeman, G., Fiers, W., Merlevede, W. and Vandenheede, J. R. (1992) Tumor necrosis factor stimulates multiple serine/threonine protein kinases in Swiss 3T3 and L929 cells. Implication of casein kinase-2 and extracellular signal-regulated kinases in the tumor necrosis factor signal transduction pathway. J. Biol. Chem. 267, 25916-25921
173. Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, S. and Spiegel, S. (1996) Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381, 800-803
174. Rao, K. M. (2001) MAP kinase activation in macrophages. J. Leukocyte Biol. 69, 3-10
175. Schievella, A. R., Chen, J. H., Graham, J. R. and Lin, L. L. (1997) MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. J. Biol. Chem. 272, 12069-12075
176. Hildt, E. and Oess, S. (1999) Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor I. J. Exp. Med. 189, 1707-1714
177. Adam-Klages, S., Adam, D., Wiegmann, K., Struve, S., Kolanus, W., Schneider-Mergener, J. and Kranke, M. (1996) FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86, 937-947
178. Kreder, D., Krut, O., Adam-Klages, S., Wiegmann, K., Scherer, G., Plitz, T., Jensen, J. M., Proksch, E., Steinmann, J., Pfeffer, K. and Kranke, M. (1999) Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice. EMBO J. 18, 2472-2479
179. Adam-Klages, S., Schwandner, R., Adam, D., Kreder, D., Bernardo, K. and Kronke, M. (1998) Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor. J. Leukocyte Biol. 63, 678-682
180. Medvedev, A. E., Sundan, A. and Espevik, T. (1994) Involvement of the tumor necrosis factor receptor p75 in mediating cytotoxicity and gene regulating activities. Eur. J. Immunol. 24, 2842-2849
181. Grell, M., Zimmermann, G., Gottfried, E., Chen, C. M., Grunwald, U., Huang, D. C., Wu Lee, Y. H., Durkop, H., Engelmann, H., Scheurich, P. et al. (1999) Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-Rl activation by endogenous membrane-anchored TNF. EMBO J. 18, 3034-3043
182. Weiss, T., Grell, M., Siemienski, K., Muhlenbeck, F., Durkop, H., Pfizenmaier, K., Scheurich, P. and Wajant, H. (1998) TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. J. Immunol. 161, 3136-3142
183. Tartaglia, L. A., Pennica, D. and Goeddel, D. V. (1993) Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 268, 18542-18548
184. Boldin, M. P., Mett, I. L. and Wallach, D. (1995) A protein related to a proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its 'death domain'. FEBS Lett. 367, 39-44
185. Song, H. Y., Dunbar, J. D., Zhang, Y. X., Guo, D. and Donner, D. B. (1995) Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor. J. Biol. Chem. 270, 3574-3581
186. Dunbar, J. D., Song, H. Y., Guo, D., Wu, L. W. and Donner, D. B. (1997) Two-hybrid cloning of a gene encoding TNF receptor-associated protein 2, a protein that interacts with the intracellular domain of the type 1 TNF receptor: identity with subunit 2 of the 26S protease. J. Immunol. 158, 4252-4259
187. Felts, S. J., Owen, B. A., Nguyen, P., Trepel, J., Donner, D. B. and Toft, D. O. (2000) The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J. Biol. Chem. 275, 3305-3312
188. Chen, C. F., Chen, Y., Dai, K., Chen, P. L., Riley, D. J. and Lee, W. H. (1996) A new member of the hsp90 family of molecular chaperones interacts with the retinoblastoma protein during mitosis and after heat shock. Mol. Cell. Biol. 16, 4691-4699
189. Gu, C., Castellino, A., Chan, J. Y. and Chao, M. V. (1998) BRE: a modulator of TNF-α action. FASEB J. 12, 1101-1108
190. Castellino, A. M., Parker, G. J., Boronenkov, I. V., Anderson, R. A. and Chao, M. V. (1997) A novel interaction between the juxtamembrane region of the p55 tumor necrosis factor receptor and phosphatidylinositol-4-phosphate 5-kinase. J. Biol. Chem. 272, 5861-5870
191. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297
192. Taganov, K. D., Boldin, M. P., Chang, K. J. and Baltimore, D. (2006) NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 103, 12481-12486
193. O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G. and Baltimore, D. (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. U.S.A. 104, 1604-1609
194. Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., van Dongen, S., Grocock, R. J., Das, P. P., Miska, E. A. et al. (2007) Requirement of bic/microRNA-155 for normal immune function. Science 316, 608-611
195. Tili, E., Michaille, J. J., Cimino, A., Costinean, S., Dumitru, C. D., Adair, B., Fabbri, M., Alder, H., Liu, C. G., Calin, G. A. and Croce, C. M. (2007) Modulation of miR-155 and miR-125b levels following lipopolysaccharide/ TNF-α stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 179, 5082-5089
196. Suarez, Y., Wang, C., Manes, T. D. and Pober, J. S. (2010) Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J. Immunol. 184, 21-25
197. MacEwan, D. J. (2008) Interactions between TNF and GnRH. Neurochem. Res. 33, 678-682
198. Bradley, J. R. (2008) TNF-mediated inflammatory disease. J. Pathol. 214, 149-160
199. Valesini, G., Iannuccelli, C., Marocchi, E., Pascoli, L., Scalzi, V. and Di Franco, M. (2007) Biological and clinical effects of anti-TNFa treatment. Autoimmun. Rev. 7, 35-41
200. Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G. and Tak, P. P. (2008) Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol. Ther. 117, 244-279
201. Murumkar, P. R., DasGupta, S., Chandani, S. R., Giridhar, R. and Yadav, M. R. (2010) Novel TACE inhibitors in drug discovery: a review of patented compounds. Expert Opin. Ther. Pat. 20, 31-57
202. Feldmann, M., Williams, R. O. and Paleolog, E. (2010) What have we learnt from targeted anti-TNF therapy? Ann. Rheum. Dis. 69 (Suppl. 1), i97-i99
203. Pfeffer, K., Matsuyama, T., Kundig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Kronke, M. and Mak, T. W. (1993) Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L monocytogenes infection. Cell 73, 457-467
204. Roach, D. R., Bean, A. G., Demangel, C., France, M. P., Briscoe, H. and Britton, W. J. (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J. Immunol. 168, 4620-4627
205. Wallis, R. S., Broder, M., Wong, J., Lee, A. and Hoq, L. (2005) Reactivation of latent granulomatous infections by infliximab. Clin. Infect. Dis. 41 (Suppl. 3), S194-S198
206. Van Hensbroek, M. B., Palmer, A., Onyiorah, E., Schneider, G., Jaffar, S., Dolan, G., Memming, H., Frenkel, J., Enwere, G., Bennett, S., Kwiatkowski, D. and Greenwood, B. (1996) The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J. Infect. Dis. 174, 1091-1097
207. Palladino, M. A., Bahjat, F. R., Theodorakis, E. A. and Moldawer, L. L. (2003) Anti-TNF-α therapies: the next generation. Nat. Rev. Drug Discov. 2, 736-746
208. O'Neill, L. A. (2006) Targeting signal transduction as a strategy to treat inflammatory diseases. Nat. Rev. Drug Discov. 5, 549-563